{
"raw_text": "```json\n{\n  \"base_id\": \"base_diabetes_0081\",\n  \"domain\": \"diabetes\",\n  \"evaluation\": {\n    \"patient_profile\": {\n      \"age_group\": \"35-44\",\n      \"sex\": \"M\",\n      \"comorbidities\": [\"type2_diabetes\", \"obesity\"],\n      \"allergies\": [\"sulfa\"]\n    },\n    \"current_therapy\": {\n      \"medications\": [\n        {\n          \"name\": \"metformin\",\n          \"dose\": \"1000mg\",\n          \"frequency\": \"BID\"\n        },\n        {\n          \"name\": \"insulin_glargine\",\n          \"dose\": \"20 units\",\n          \"frequency\": \"QHS\"\n        }\n      ],\n      \"adequacy\": \"Therapy consistent with standard treatment for type 2 diabetes with obesity\"\n    },\n    \"vitals\": {\n      \"blood_pressure_systolic\": 132,\n      \"heart_rate\": 78,\n      \"interpretation\": \"Vitals within acceptable ranges\"\n    },\n    \"laboratory_results\": {\n      \"HbA1c\": 7.8,\n      \"creatinine\": 1.0,\n      \"eGFR\": 88,\n      \"interpretation\": \"HbA1c slightly above target (<7% typically); renal function within normal limits\"\n    },\n    \"clinical_summary\": \"Patient is a middle-aged male with type 2 diabetes and obesity, managed on metformin and basal insulin (insulin glargine). Glycemic control is suboptimal given HbA1c of 7.8%, suggesting potential need for therapy optimization. Kidney function is stable. No contraindications noted based on allergy profile. Continue monitoring and consider lifestyle optimization and medication adjustment if clinically indicated.\",\n    \"disclaimer\": \"FOR EVALUATION ONLY - NOT CLINICAL USE.\"\n  }\n}\n```",
"model_id": "openai",
"version": "gpt-4.1-mini",
"prompt_tokens": 351,
"completion_tokens": 390,
"latency_seconds": 5.126114799990319
}